Solventum Corp (SOLV): Long-Term Debt
$5.04B
As of 2025-12-31
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.04B | -37.1% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $8.01B | n/a | 2026-02-27, Balance as of period end |
| 2023-12-31 | $0 | n/a | 2025-02-28, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Solventum Corp (SOLV) | 2025-12-31 | $5.04B | -37.1% |
| Baxter International Inc (BAX) | 2025-12-31 | $9.44B | -28.4% |
| ResMed Inc (RMD) | 2026-06-30 | $399.42M | -39.3% |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $202.80M | +0.1% |
| 3M Co (MMM) | 2025-12-31 | $12.60B | -3.4% |
| Teleflex Inc (TFX) | 2025-12-31 | $2.64B | +59.5% |
| Integra Lifesciences Holdings Corp (IART) | 2025-12-31 | $726.56M | -4.5% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $734.04M | +0.6% |
| Haemonetics Corp (HAE) | 2026-03-28 | $1.24B | -0.5% |
Compare SOLV, BAX, RMD, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗